SCHEMBL416181

SCHEMBL416181

CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 1.00
PPARD Q03181 6/20 1.00
PPARA Q07869 6/20 1.00
ALDH1A1 P00352 5/20 1.00
F7 P08709 5/20 1.00
F3 P13726 5/20 1.00
FABP4 P15090 4/20 1.00
HSD17B10 Q99714 4/20 1.00
FFAR1 O14842 3/20 1.00
PTGS1 P23219 3/20 1.00
LMNA P02545 3/20 1.00
CYP19A1 P11511 3/20 1.00
ALOX15 P16050 3/20 1.00
NR4A2 P43354 3/20 1.00
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 2/20 1.00
HPGD P15428 2/20 1.00
AKR1C3 P42330 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
DUSP3 P51452 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16685715 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL15880317 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Linoleic Acid SCHEMBL20856202 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498259 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498256 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Arachidic Acid SCHEMBL20528087 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Linoleic Acid SCHEMBL25294178 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL22498258 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
Dihomo-Gamma-Linolenic Acid SCHEMBL20656585 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7
SCHEMBL21411004 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 449 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709912-A1 PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS BioAtla, Inc. (US) 2026-03-18 EP claimed
WO-2026041693-A1 HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS SPSV B.V. (NL) 2026-02-26 WO claimed
EP-4700098-A1 HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS SPSV B.V. (NL) 2026-02-25 EP claimed
US-20250304916-A1 METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS TRAILHEAD BIOSYSTEMS INC (US) 2025-10-02 US claimed
WO-2025093572-A1 SOLID DISPERSION COMPOSITIONS AND USES THEREOF TRx Biosciences Limited (GB) 2025-05-08 WO claimed
EP-3554254-B1 COMPOSITIONS AND METHODS THAT MODULATE BACTERIA IN A COMPANION ANIMAL NESTLE SA (CH) 2025-05-07 EP claimed
CN-119677509-A Fibrate composition for the treatment of inflammation and neuroinflammation 特瑞克思生物科学有限公司 2025-03-21 CN claimed
EP-4493178-A1 FIBRATE COMPOSITIONS FOR TREATING INFLAMMATION AND NEUROINFLAMMATION TRX Biosciences Limited (GB) 2025-01-22 EP claimed
EP-4493151-A2 COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS AND USES THEREOF TRX Biosciences Limited (GB) 2025-01-22 EP claimed
WO-2024232976-A1 PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS BIOATLA, INC. (US) 2024-11-14 WO claimed
EP-1765894-B9 NOVEL TEMPERATURE AND PH SENSITIVE COPOLYMERS AGENCY SCIENCE TECH & RES (SG) 2012-08-01 EP claimed
WO-2012080279-A1 RADIOPAQUE IODINATED PRODUCTS INTENDED FOR USE MEDICAL IMAGING AND THEIR METHODS OF PREPARATION UNIVERSITE DE STRASBOURG (FR) 2012-06-21 WO claimed
EP-1765894-B1 NOVEL TEMPERATURE AND PH SENSITIVE COPOLYMERS AGENCY SCIENCE TECH & RES (SG) 2012-03-28 EP claimed
US-7824866-B2 Ligand for G-protein coupled receptor GPR72 and uses thereof EUROSCREEN S.A. (BE) 2010-11-02 US claimed
EP-2231173-A1 NUTRACEUTICAL COMPOSITION AND METHODS OF USE Dacy Tech Pty Ltd (AU) 2010-09-29 EP claimed
WO-2009073930-A1 NUTRACEUTICAL COMPOSITION AND METHODS OF USE DACY TECH PTY LTD (AU) 2009-06-18 WO claimed
US-20090068190-A1 ANTI-PROLIFERATIVE COMBINATIONS DRUGTECH CORPORATION (US) 2009-03-12 US claimed
US-20080274124-A1 Ligand for G-protein coupled receptor GPR72 and uses thereof EUROSCREEN S. A. 2008-11-06 US claimed
EP-1867994-A2 Ligand for G-protein coupled receptor GPR72 and uses thereof Euroscreen S.A. (BE) 2007-12-19 EP claimed
EP-1354200-B1 METHOD OF SCREENING FOR GPR40 LIGANDS GLAXO GROUP LTD (GB) 2007-01-24 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068190-A1 ANTI-PROLIFERATIVE COMBINATIONS FOLR2, FOLR1, DHFR PPARG 164/4885PPARD 166/4885PPARA 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.